Company profile: CryoTherapeutics
1.1 - Company Overview
Company description
- Provider of a proprietary intracoronary cryotherapy system (CTS) for the treatment of coronary artery disease, designed to stabilize high-risk plaque lesions and potentially prevent heart attacks without leaving a stent. Offerings include a patented catheter and console interface for localized cryoenergy delivery, and ongoing clinical trials, including the POLARSTAR study, to demonstrate safety and efficacy for regulatory approval.
Products and services
- CTS System: Proprietary intracoronary cryotherapy system that stabilizes high-risk coronary plaque to prevent heart attacks, using a patented catheter for localized treatment without leaving a stent, with demonstrated cardiovascular safety and efficacy
- Catheter-Console Interface: Console-controlled component that delivers cryoenergy by metering the cooling agent and positioning the catheter precisely at the vulnerable plaque site for localized intracoronary treatment
- Clinical Trials: Regulatory-focused studies evaluating CTS system safety and efficacy, aiming to demonstrate intracoronary treatment of vulnerable plaque lesions and support approval for coronary artery disease indications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CryoTherapeutics
nContact
HQ: United States
Website
- Description: Provider of medical devices supporting endoscopic treatments for heart rhythm disorders and arrhythmias, including atrial fibrillation (AF). Offers the Numeris Coagulation System with VisiTrax, integrating suction, perfusion, and RF energy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full nContact company profile →
Bolt Medical
HQ: United States
Website
- Description: Provider of investigational medical devices for calcified arterial lesions, including Bolt IVLTM/Bolt IVL intravascular lithotripsy using laser-based acoustic pressure waves for coronary and peripheral arteries; RESTORE ATK/BTK systems for peripheral arterial disease above/below the knee; and the RESTORE FIH Coronary System, all under clinical evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bolt Medical company profile →
FlowMedica
HQ: United States
Website
- Description: Provider of intravascular systems for implementing targeted renal therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FlowMedica company profile →
Adona Medical
HQ: United States
Website
- Description: Provider of heart failure management systems, including the Adona Interatrial Shunt with integrated bi-atrial pressure monitoring enabling individualized shunting; bi-atrial pressure sensors delivering direct LA and RA readings with >5 automated readings/day; shape memory Nitinol shunt lumen adjustment technology; and the Adona Induction Catheter for non-contact inductive energy transfer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adona Medical company profile →
Jotec
HQ: Germany
Website
- Description: Provider of medical devices for aortic and peripheral vascular disease, offering conventional vascular grafts and interventional stent graft implants for vascular and cardiac surgery and radiology/cardiology. Portfolio includes custom-made and off-the-shelf multibranch systems for aortic arch, thoracic and thoracoabdominal aneurysms, with features for secure fixation, optimized flow, visibility, reduced procedure time, and sealing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jotec company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CryoTherapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CryoTherapeutics
2.2 - Growth funds investing in similar companies to CryoTherapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CryoTherapeutics
4.2 - Public trading comparable groups for CryoTherapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →